Cargando…
Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
SIMPLE SUMMARY: Osteosarcoma is a bone cancer with a poor prognosis. This is, in part, due to resistance to current standard-of-care chemotherapeutic treatment. As personalized treatment plans become more widely utilized, the role of patient-specific genome markers may serve to identify individuals...
Autores principales: | Lee, Adam M., Ferdjallah, Asmaa, Moore, Elise, Kim, Daniel C., Nath, Aritro, Greengard, Emily, Huang, R. Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538287/ https://www.ncbi.nlm.nih.gov/pubmed/34681828 http://dx.doi.org/10.3390/ijms222011168 |
Ejemplares similares
-
The Long Non-Coding RNA ANRIL in Cancers
por: Sanchez, Aymeric, et al.
Publicado: (2023) -
The role of long non-coding RNA ANRIL in the development of atherosclerosis
por: Gareev, Ilgiz, et al.
Publicado: (2022) -
The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy
por: Chen, ShuZe, et al.
Publicado: (2019) -
Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway
por: Yu, Guangyang, et al.
Publicado: (2018) -
Long Non-coding RNA ANRIL in the Nucleus Associates With Periostin Expression in Breast Cancer
por: Mehta-Mujoo, Paulomi M., et al.
Publicado: (2019)